February 22, 2021 |
To mark Rare Disease Day 2021 on Sunday 28 February, OPEN Health will be intentionally quiet on all LinkedIn channels from 26 February to 1 March in order not to distract from awareness generated by patient groups.
To mark Rare Disease Day 2021 on Sunday 28 February, OPEN Health will be intentionally quiet on all LinkedIn channels from 26 February to 1 March in order not to distract from awareness generated by patient groups.
In fact, we want to offer our platform to amplify the voices of the rare disease community and we will be sharing Rare Disease Day-related content during this period. So, if you are part of a patient group and would like us to share your posts, please tag #Share4Rare and we will happily share to our network.
We recognise the importance of this day for rare disease patient groups in supporting their communities and raising awareness, and it’s for this reason that OPEN Health is saying “Shhhh” on Rare Disease Day 2021!
If you would like to understand more about our commitment, capabilities and experience in rare disease please contact:
Gavin Jones, Global Advisor, Rare Diseases
This content was provided by OPEN Health
Company Details
Latest Content from OPEN Health
Written by Briony Frost, OPEN Health
Written by Jess Ingram and Francisca Costa, OPEN Health
Written by Gavin Jones, Dr Alexandra Safronova & Professor Peter Rutherford, OPEN Health
Written by Gavin Jones, OPEN Health
Enhanced expertise to deliver impactful internal training programmes for healthcare clients
Gavin Jones, Director of Rare Disease, OPEN Health takes 15 minutes to answer some key questions on healthcare communications in gene therapy
New for 2020, OPEN Health is pleased to announce its sponsorship of MedComms Networking
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications
Gemma Allen, Head of Digital Communications, OPEN Health takes 15 minutes to answer some key questions on digital in medical communications
Gene therapy and advanced cell-based therapies offer patients hope and the potential to make them ‘chronically well’.
